About 1 in 6 women were found to experience symptoms of postpartum depression 2 months after cesarean delivery.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

The firm specialises in high-specification furniture for leading universities including Cambridge and Loughborough, research ...

There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...

Shalini Kumar has joined Kenvue as Head - Consumer Experience. Shalini was earlier with Halenon as Area Media Lead for ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

GlaxoSmithKline Pharmaceuticals and Sasken Technologies have released their financial results for the quarter that ended on ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.